D
Altimmune, Inc. ALT
$3.93 $0.000.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -13.13% 15.55% -1.47% 7.28% -1.01%
Total Depreciation and Amortization 3.45% -12.12% -10.81% -39.34% -42.99%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -24.59% 37.06% 15.86% -37.04% 23.93%
Change in Net Operating Assets 134.38% -124.68% 138.52% -302.69% -39.94%
Cash from Operations -14.90% 7.80% 32.65% -49.76% -10.70%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 2,082.30% -137.42% 1,036.95% 132.44% 90.65%
Cash from Investing 2,082.10% -137.42% 1,036.95% 132.44% 90.65%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 8.32% 246.21% 3,635.93% 36.36% -41.59%
Repurchase of Common Stock 99.12% -33,800.00% 50.00% 98.36% 59.33%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -361.60% -- -- -- --
Cash from Financing 53.12% 238.31% 3,691.35% 678.26% 82.38%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 1,000.35% 123.37% 121.25% -17.41% 61.08%